1887

Abstract

Milk contains a wide variety of host protective factors against infectious microbes. Among these protective factors, lactoferrin (LF) and lactoperoxidase (LPO) have been reported to exhibit antiviral activities as well as immuno-modulatory effects. In the present study, the effects of orally administered LF and LPO were assessed in a mouse influenza virus infection model. BALB/c mice were intranasally infected with 6.6 × 10 p.f.u. of influenza virus A/PR/8/34(H1N1). Bovine LF or LPO was administered once daily at a dose of 62.5 mg per mouse by gavage, starting 1 day before infection. Mice given LF or LPO showed a significantly lower lung consolidation score on day 6 after infection compared with the control mice that were given water instead. Concurrently, the number of infiltrated leukocytes recovered from bronchoalveolar lavage fluid (BALF) on day 6 was significantly lower in mice given LF or LPO. However, the virus yield in the BALF was not affected by these treatments. The serum level of IL-6, a pro-inflammatory cytokine, positively correlated with the lung consolidation score in each group and was significantly lower on day 6 in the mice given LPO. These results suggest the potential of oral administration of LF or LPO to attenuate pneumonia in influenza-virus-infected mice through the suppression of infiltration of inflammatory cells in the lung.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.46018-0
2005-08-01
2019-09-17
Loading full text...

Full text loading...

/deliver/fulltext/jmm/54/8/JM540803.html?itemId=/content/journal/jmm/10.1099/jmm.0.46018-0&mimeType=html&fmt=ahah

References

  1. Conn, C. A., McClellan, J. L., Maassab, H. F., Smitka, C. W., Majde, J. A. & Kluger, M. J. ( 1995;). Cytokines and acute phase response to influenza virus in mice. Am J Physiol 268, R78–R84.
    [Google Scholar]
  2. Conner, G. E., Salathe, M. & Forteza, R. ( 2002;). Lactoperoxidase and hydrogen peroxide metabolism in the airway. Am J Respir Crit Care Med 166, S57–S61.[CrossRef]
    [Google Scholar]
  3. Cross, M. L. & Gill, H. S. ( 1999;). Modulation of immune function by a modified bovine whey protein concentrate. Immunol Cell Biol 77, 345–350.[CrossRef]
    [Google Scholar]
  4. Deliyannis, G., Jackson, D. C., Ede, N. J., Zeng, W., Hourdakis, I., Sakabetis, E. & Brown, L. E. ( 2002;). Induction of long-term memory CD8+ T cells for recall of viral clearing responses against influenza virus. J Virol 76, 4212–4221.[CrossRef]
    [Google Scholar]
  5. Di Mario, F., Aragona, G., Bo, N. D. & 7 other authors ( 2003;). Use of lactoferrin for Helicobacter pylori eradication.Preliminary results. J Clin Gastroenterol 36, 396–398.[CrossRef]
    [Google Scholar]
  6. Floris, R., Recio, I., Berkhout, B. & Visser, S. ( 2003;). Antibacterial and antiviral effects of milk proteins and derivatives thereof. Curr Pharm Des 9, 1257–1275.[CrossRef]
    [Google Scholar]
  7. Hashiba, T., Suzuki, M., Nagashima, Y., Suzuki, S., Inoue, S., Tsuburai, T., Matsuse, T. & Ishigatubo, Y. ( 2001;). Adenovirus-mediated transfer of heme oxygenase-1 cDNA attenuates severe lung injury induced by the influenza virus in mice. Gene Ther 8, 1499–1507.[CrossRef]
    [Google Scholar]
  8. Haversen, L. A., Engberg, I., Baltzer, L., Dolphin, G., Hanson, L. A. & Mattsby-Baltzer, I. ( 2000;). Human lactoferrin and peptides derived from a surface-exposed helical region reduce experimental Escherichia coli urinary tract infection in mice. Infect Immun 68, 5816–5823.[CrossRef]
    [Google Scholar]
  9. Haversen, L., Ohlsson, B. G., Hahn-Zoric, M., Hanson, L. A. & Mattsby-Baltzer, I. ( 2002;). Lactoferrin down-regulates the LPS-induced cytokine production in monocytic cells via NF-κB. Cell Immunol 220, 83–95.[CrossRef]
    [Google Scholar]
  10. Hooijdonk, A. C. M. V., Kussendrager, K. D. & Steijns, J. M. ( 2000;). In vivo antimicrobial and antiviral activity of components in bovine milk and colostrum involved in non-specific defence. Br J Nutr 84, S127–S134.
    [Google Scholar]
  11. Ishii, K., Takamura, N., Shinohara, M., Wakui, N., Shin, H., Sumino, Y., Ohmoto, Y., Teraguchi, S. & Yamauchi, K. ( 2003;). Long-term follow-up of chronic hepatitis C patients treated with oral lactoferrin for 12 months. Hepatol Res 25, 226–233.[CrossRef]
    [Google Scholar]
  12. Kaiser, L., Fritz, R. S., Straus, S. E., Gubareva, L. & Hayden, F. G. ( 2001;). Symptom pathogenesis during acute influenza: interleukin-6 and other cytokine responses. J Med Virol 64, 262–268.[CrossRef]
    [Google Scholar]
  13. Kawasaki, Y., Isoda, H., Shinmoto, H., Tanimoto, M., Dosako, S., Idota, T. & Nakajima, I. ( 1993;). Inhibition by κ-casein glycomacropeptide and lactoferrin of influenza virus hemagglutination. Biosci Biotechnol Biochem 57, 1214–1215.[CrossRef]
    [Google Scholar]
  14. Kozak, W., Poli, V., Soszynski, D., Conn, C. A., Leon, L. R. & Kluger, M. J. ( 1997;). Sickness behavior in mice deficient in interleukin-6 during turpentine abscess and influenza pneumonitis. Am J Physiol 272, R621–R630.
    [Google Scholar]
  15. Kurokawa, M., Ochiai, H., Nakajima, K. & Niwayama, S. ( 1990;). Inhibitory effect of protein kinase C inhibitor on the replication of influenza type A virus. J Gen Virol 71, 2149–2155.[CrossRef]
    [Google Scholar]
  16. Lefkowitz, D. L., Lefkowitz, S. S., Mone, J. & Everse, J. ( 1988;). Peroxidase-induced enhancement of chemiluminescence by murine peritoneal macrophages. Life Sci 43, 739–745.[CrossRef]
    [Google Scholar]
  17. Lefkowitz, D. L., Hsieh, T.-C., Millis, K. & Castro, A. ( 1990;). Induction of tumor necrosis factor and cytotoxicity by macrophages exposed to lactoperoxidase and microperoxidase. Life Sci 47, 703–709.[CrossRef]
    [Google Scholar]
  18. Lönnerdal, B. & Iyer, S. ( 1995;). Lactoferrin: molecular structure and biological function. Annu Rev Nutr 15, 93–110.[CrossRef]
    [Google Scholar]
  19. Maeda, H. & Akaike, T. ( 1991;). Oxygen free radicals as pathogenic molecules in viral diseases. Proc Soc Exp Biol Med 198, 721–727.[CrossRef]
    [Google Scholar]
  20. Mikola, H., Waris, M. & Tenovuo, J. ( 1995;). Inhibition of herpes simplex virus type 1, respiratory syncytial virus and echovirus type 11 by peroxidase-generated hypothiocyanate. Antiviral Res 26, 161–171.[CrossRef]
    [Google Scholar]
  21. Mogensen, T. H. & Paludan, S. R. ( 2001;). Molecular pathways in virus-induced cytokine production. Microbiol Mol Biol Rev 65, 131–150.[CrossRef]
    [Google Scholar]
  22. Mori, K., Kido, T., Daikuhara, H., Sakakibara, I., Sakata, T., Shimizu, K., Amagaya, S., Sasaki, H. & Komatsu, Y. ( 1999;). Effect of Hochu-ekki-to (TJ-41), a Japanese herbal medicine, on the survival of mice infected with influenza virus. Antiviral Res 44, 103–111.[CrossRef]
    [Google Scholar]
  23. Pourtois, M., Binet, C., Tieghem, N. V., Courtois, P., Vandenabbeele, A. & Thiry, L. ( 1990;). Inhibition of HIV infectivity by lactoperoxidase-produced hypothiocyanite. J Biol Buccale 18, 251–253.
    [Google Scholar]
  24. Reiter, B., Marshall, V. M. & Philips, S. M. ( 1980;). The antibiotic activity of the lactoperoxidase-thiocyanate-hydrogen peroxide system in the calf abomasum. Res Vet Sci 28, 116–122.
    [Google Scholar]
  25. Sidwell, R. W., Huffman, J. H., Bailey, K. W., Wong, M. H., Nimrod, A. & Panet, A. ( 1996;). Inhibitory effects of recombinant manganese superoxide dismutase on influenza virus infections in mice. Antimicrob Agents Chemother 40, 2626–2631.
    [Google Scholar]
  26. Takakura, N., Wakabayashi, H., Ishibashi, H., Yamauchi, K., Teraguchi, S., Tamura, Y., Yamaguchi, H. & Abe, S. ( 2004;). Effect of orally administered bovine lactoferrin on the immune response in the oral candidiasis murine model. J Med Microbiol 53, 495–500.[CrossRef]
    [Google Scholar]
  27. Tanaka, K., Ikeda, M., Nozaki, A., Kato, N., Tsuda, H., Saito, S. & Sekihara, H. ( 1999;). Lactoferrin inhibits hepatitis C virus viremia in patients with chronic hepatitis C: a pilot study. Jpn J Cancer Res 90, 367–371.[CrossRef]
    [Google Scholar]
  28. Tenovuo, J. ( 2002;). Clinical applications of antimicrobial host proteins lactoperoxidase, lysozyme and lactoferrin in xerostomia: efficacy and safety. Oral Dis 8, 23–29.[CrossRef]
    [Google Scholar]
  29. Togawa, J., Nagase, H., Tanaka, K., Inamori, M., Nakajima, A., Ueno, N., Saito, T. & Sekihara, H. ( 2002;). Oral administration of lactoferrin reduces colitis in rats via modulation of the immune system and correction of cytokine imbalance. J Gastroenterol Hepatol 17, 1291–1298.[CrossRef]
    [Google Scholar]
  30. Tsurita, M., Kurokawa, M., Imakita, M., Fukuda, Y., Watanabe, Y. & Shiraki, K. ( 2001;). Early augmentation of interleukin (IL)-12 level in the airway of mice administered orally with clarithromycin or intranasally with IL-12 results in alleviation of influenza infection. J Pharmacol Exp Ther 298, 362–368.
    [Google Scholar]
  31. van der Strate, B. W. A., Beljaas, L., Molema, G., Harmsen, M. C. & Meijer, D. F. K. ( 2001;). Antiviral activities of lactoferrin. Antiviral Res 52, 225–239.[CrossRef]
    [Google Scholar]
  32. Vorland, L. H. ( 1999;). Lactoferrin: a multifunctional glycoprotein. APMIS 107, 971–981.[CrossRef]
    [Google Scholar]
  33. Wakabayashi, H., Kurokawa, M., Shin, K., Teraguchi, S., Tamura, Y. & Shiraki, K. ( 2004;). Oral lactoferrin prevents body weight loss and increases cytokine responses during herpes simplex virus type 1 infection of mice. Biosci Biotechnol Biochem 68, 537–544.[CrossRef]
    [Google Scholar]
  34. Wang, W., Iigo, M., Sato, J., Sekine, K., Adachi, I. & Tsuda, H. ( 2000;). Activation of intestinal mucosal immunity in tumor-bearing mice by lactoferrin. Jpn J Cancer Res 91, 1022–1027.[CrossRef]
    [Google Scholar]
  35. Wong, C. W., Regester, G. O., Francis, G. L. & Watson, D. L. ( 1996;). Immunomodulatory activities of whey fractions in efferent prefemoral lymph of sheep. J Dairy Res 63, 257–267.[CrossRef]
    [Google Scholar]
  36. Wong, C. W., Seow, H. F., Husband, A. J., Regester, G. O. & Watson, D. L. ( 1997;). Effects of purified bovine whey factors on cellular immune functions in ruminants. Vet Immunol Immunopathol 56, 85–96.[CrossRef]
    [Google Scholar]
  37. Yamauchi, K., Hiruma, M., Yamazaki, N., Wakabayashi, H., Kuwata, H., Teraguchi, S., Hayasawa, H., Suegara, N. & Yamaguchi, H. ( 2000;). Oral administration of bovine lactoferrin for the treatment of tinea pedis.A placebo-controlled, double-blind study. Mycoses 43, 197–202.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.46018-0
Loading
/content/journal/jmm/10.1099/jmm.0.46018-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error